TO SEE THE EFFECT OF HARBAL DRUGS ON TAMAKA SHWASA

PHYSIOLOGICAL STUDY OF PRANAVAHA SROTAS W.S.R. TO EFFECT OF KULATTHGUDA LEHA IN â??TAMAKA SHWASAâ??

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/11/016386

Enrollment

Registered

2018-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J96-J99- Other diseases of the respiratory system

Interventions

Intervention1: KULATTHGUDA LEHA 6-12 gm twice a day orally for 45 days: Kulattha Bilva Agnimantha Shyonaka Patala Gambhari Brihati Kantakari Shalaparni Prishnaparni Gokshura Bharangi Vanshlochan Pippl

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical signs and symptoms of Tamaka Shwasa as mentioned in Ayurvedic and modern texts

Exclusion criteria

Exclusion criteria: Following patients will not be registered for present clinical trial: Tuberculosis Pleural effusion Cardiac asthma Emphysema COPD (Chronic obstructive pulmonary disease) Bronchial Carcinoma Age below 16 years & above 70 years. Status Asthmatics Patients suffering from serious systemic disorders like renal failure, hypertension etc

Design outcomes

Primary

Measure	Time frame
to treat tamaka shawasa patientTimepoint: one year	—

Secondary

Measure	Time frame
check the efficacy of kulatthguda leha and vasavleha in tamaka shawasa patientTimepoint: one year	—

Countries

India

Contacts

Public ContactPROF HEMRAJ MEENA

NATIONAL INSTITUTE OF AYURVEDA

dr.hrmeena@gmail.com9414010347

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026